At the same time, those patients infected with COVID-19 exhibited a reduced total number of T cells and increased concentrations of IL-6 and IL-10, which are risk factors that aggravate the severity of COVID-19 in patients with lung cancer (13). This evidence concerns the gene IL6 and COVID-19.